• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 16, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Alzheimer Europe outlines state-of-play of dementia policy in Europe

Bioengineer by Bioengineer
March 30, 2021
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Alzheimer Europe has launched a new report, ‘Dementia Monitor 2020’, providing a high-level overview of how countries across Europe have responded to the challenges posed by dementia

IMAGE

Credit: Alzheimer Europe

Luxembourg, 30 March 2021 – Alzheimer Europe has launched a new report, “Dementia Monitor 2020”, providing a high-level overview of how countries across Europe have responded to the challenges posed by dementia.

Alzheimer Europe’s Dementia Monitor 2020, provides a high-level overview of countries across Europe, outlining their responses to dementia, across 10 areas, including care and support services, participation in European research, policy drivers and legal protections. The report was developed by Alzheimer Europe, working together with its national member associations.

Alzheimer Europe published a similar report in 2017 which established a benchmark for countries and has made it possible to identify changes in the dementia landscape over the past three years.

Some key highlights from the Dementia Monitor 2020 include:

  • Care and support services continue to be largely insufficiently available, despite some minor improvements since 2017
  • A majority of care and support services continue to receive some level of financial support from the state (either fully funded or co-funded)
  • An increasing number of countries are engaging in policy processes designed to prioritise dementia, for example, through the development of dementia strategies
  • Countries in central and eastern Europe continue to be less well represented in clinical trials related to dementia
  • A majority of countries continue to have a poor level of legal protections in place to guarantee the rights of people with dementia or carers, particularly in relation to employment matters
  • There continues to be significant differences between Western and Northern European countries and those in Central and Eastern Europe in terms of how governments are responding to dementia.

Commenting on the launch of the report, Alzheimer Europe’s Executive Director, Jean Georges, stated:

“There is a mixed picture emerging from the Dementia Monitor 2020. Whilst we have seen some minor improvements in the availability and affordability of care since the 2017 Dementia Monitor, it remains the case that overall, too many services remain insufficiently available.

Whilst progress in the areas of policy and international commitments are certainly welcome, it is evident that there is still much work to do in order to translate commitments on paper into everyday reality for people living with dementia.

The number of people with dementia in Europe is likely to double by 2050, increasing from 9.78 million to 18.8 million. People with dementia and their carers must be supported throughout the duration of the illness, from the point of diagnosis through until the end of life. If this is to be achieved, particularly in light of an inevitable increase in demand for supports and services, we must see significant investment in health and social care systems to fix the shortcomings in the availability and financial support, as well as securing their long-term sustainability.

Alzheimer Europe strongly calls upon the EU to use its Cohesion Funds, including the EU4Health programme, to support Member States to address the identified gaps in care and support services for people living with dementia.”

###

To download (PDF): http://bit.ly/DementiaMonitor2020

For further information, contact: Jean Georges, Executive Director, Alzheimer Europe, 14, rue Dicks, L-1417 Luxembourg, Tel.: +352-29 79 70, Fax: +352-29 79 72, [email protected], http://www.alzheimer-europe.org

Notes to editors:

Alzheimer Europe is the umbrella organisation of national Alzheimer associations and currently has 37 member organisations in 33 European countries. The mission statement of the organisation is to change perceptions, practice and policy to ensure equal access of people with dementia to a high level of care services and treatment options.

The 10 categories covered by the Dementia Monitor 2020 are:

    1. The availability of care services

    2. The affordability of care services

    3. The reimbursement of medicines

    4. The availability of clinical trials

    5. The involvement of the country in European dementia research initiatives

    6. The recognition of dementia as a priority

    7. The development of dementia-friendly initiatives

    8. The recognition of legal rights

    9. The ratification of International and European human rights treaties

    10. Care and employment rights.

To support people with dementia, carers and Alzheimer’s associations during the COVID-19 pandemic, the organisation has dedicated a special section of its website to useful resources and links: https://www.alzheimer-europe.org/Living-with-dementia/COVID-19

Media Contact
Jean Georges
[email protected]

Tags: AgingAlzheimer
Share12Tweet8Share2ShareShareShare2

Related Posts

Intratracheal Budesonide Boosts Preterm Infant Lung Health

Intratracheal Budesonide Boosts Preterm Infant Lung Health

August 16, 2025
Gallbladder Removal Disrupts Gut Microbes, Fuels Tumors

Gallbladder Removal Disrupts Gut Microbes, Fuels Tumors

August 16, 2025

Medical Staff Views on NAVA in Preterm Infants

August 16, 2025

NIH Grant Supports Innovative Research Targeting the Root Causes of HIV Persistence

August 16, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    140 shares
    Share 56 Tweet 35
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    79 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    59 shares
    Share 24 Tweet 15
  • Predicting Colorectal Cancer Using Lifestyle Factors

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Nab-Paclitaxel Combo Outperforms Gemcitabine in Biliary Cancer

Neonatal Cord Metabolome Links to Teen Heart Health

Intratracheal Budesonide Boosts Preterm Infant Lung Health

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.